Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$1.52 | -$1.44 | -$1.48 |
| Q2 2026 | 1 | -$1.28 | -$1.22 | -$1.25 |
| Q3 2026 | 1 | -$1.10 | -$1.04 | -$1.07 |
| Q4 2026 | 1 | -$0.92 | -$0.88 | -$0.90 |
| Q1 2027 | 1 | -$0.77 | -$0.73 | -$0.75 |
| Q2 2027 | 1 | -$0.54 | -$0.52 | -$0.53 |
| Q3 2027 | 1 | -$0.45 | -$0.43 | -$0.44 |
| Q4 2027 | 1 | -$0.35 | -$0.33 | -$0.34 |
| Q1 2028 | 1 | -$0.31 | -$0.29 | -$0.30 |
| Q2 2028 | 1 | -$0.28 | -$0.26 | -$0.27 |
| Q3 2028 | 1 | -$0.26 | -$0.24 | -$0.25 |
| Q4 2028 | 1 | -$0.22 | -$0.20 | -$0.21 |
DarioHealth Corp last posted its earnings results on Wednesday, May 13th, 2026. The company reported $-1.25 earnings per share for the quarter, topping analysts' consensus estimates of $-1.48 by $0.23. The company had revenue of 5.58 M for the quarter and had revenue of 22.36 M for the year. DarioHealth Corp has generated $1 earnings per share over the last year ($1.24 diluted earnings per share) and currently has a price-to-earnings ratio of 5.08. DarioHealth Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/13/2026 | Q1 2026 | -$1.48 | $1.25 | 2.73 | $5.46 M | $5.58 M |
| 03/19/2026 | Q4 2025 | -$2.44 | $1.90 | 4.34 | $5.05 M | $5.23 M |
| 11/13/2025 | Q3 2025 | -$2.63 | $0.38 | 3.01 | $5.67 M | $5.01 M |
| 08/12/2025 | Q2 2025 | -$2.20 | -$0.20 | 2 | $6.91 M | $5.37 M |
| 05/14/2025 | Q1 2025 | -$1.40 | $0.14 | 1.54 | $7.47 M | $6.75 M |
| 03/10/2025 | Q4 2024 | -$3.20 | -$0.26 | 2.94 | $7.39 M | $7.60 M |
| 11/07/2024 | Q3 2024 | -$3.60 | $0.36 | 3.96 | $7.40 M | $7.42 M |
| 08/08/2024 | Q2 2024 | -$5.80 | -$0.08 | 5.72 | $7.92 M | $6.26 M |
| 05/15/2024 | Q1 2024 | -$11.80 | -$0.20 | 11.6 | $6.76 M | $5.76 M |
| 03/28/2024 | Q4 2023 | -$10.80 | -$0.44 | 10.36 | N/A | $3.62 M |
| 11/02/2023 | Q3 2023 | -$10.00 | -$0.49 | 9.51 | N/A | $3.52 M |
| 08/10/2023 | Q2 2023 | -$10.40 | -$0.59 | 9.81 | N/A | $6.15 M |
| 05/11/2023 | Q1 2023 | -$9.20 | $0.45 | 9.65 | N/A | $7.07 M |
| 03/09/2023 | Q4 2022 | -$12.00 | -$0.49 | 11.51 | N/A | $6.81 M |
| 11/14/2022 | Q3 2022 | -$16.60 | -$0.73 | 15.87 | N/A | $6.61 M |
| 08/15/2022 | Q2 2022 | -$15.40 | -$0.80 | 14.6 | N/A | $6.18 M |
| 05/11/2022 | Q1 2022 | -$19.60 | -$0.81 | 18.79 | N/A | $8.06 M |
| 03/21/2022 | Q4 2021 | -$22.60 | -$1.38 | 21.22 | N/A | $6.03 M |
| 11/15/2021 | Q3 2021 | -$19.00 | -$1.36 | 17.64 | N/A | $5.63 M |
| 08/16/2021 | Q2 2021 | -$16.80 | -$1.13 | 15.67 | N/A | $5.26 M |
In the previous quarter, DarioHealth Corp (:DRIO) reported $-1.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.48 by $0.23.
The conference call for DarioHealth Corp's latest earnings report can be listened to online.
The conference call transcript for DarioHealth Corp's latest earnings report can be read online.
DarioHealth Corp (:DRIO) has a recorded annual revenue of $22.36 M.
DarioHealth Corp (:DRIO) has a recorded net income of $-41,714,000.DarioHealth Corp has generated $1.24 earnings per share over the last four quarters.
DarioHealth Corp (:DRIO) has a price-to-earnings ratio of 5.08 and price/earnings-to-growth ratio is 0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED